Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

2
Royal Gold (RGLD) Provides Updates on Operations For Q4

2018-07-10 zacks
Our experts cut down 220 Zacks Rank #1 Strong Buys to the 7 most likely to jump in price immediately.
RGLD RGL

1
A Gold Turnaround In Microcosm

2018-07-05 seekingalpha
Gold caught a breather from its latest plunge on Tuesday and offered participants at least some hope of a relief rally. The rationale for a gold summer rally was actually offered in microcosm on Tuesday’s trading session, as I’ll explain in today’s commentary. While the downward trend remains intact for the metal, once the latest wave of tariff-related weakness in the equity market has abated, gold should be able to finally experience at least a short-term turnaround.
RGLD GDX IAU RGL

9
Gold Mining Bull: Top News For June 2018

2018-07-03 seekingalpha
Here's a monthly recap of the top news in the gold mining sector, including acquisitions and takeover announcements, financial results and other relevant updates, to keep readers up-to-date on news in the sector. Here's my update for May, in case you missed it.
AGCBF RIO RIO YRI KGI.DB CG CAGDF RTPPF FPC AUY OR RTNTF FPRGF SEMFF KL WPM SAND SSL SDDXF KGI OKSWF KGI.DB.A SNXZF RGLD AGC RIO OSKGF RGL

1
Amarillo Gold Announces Completion of the Sale of an NSR Royalty to Royal Gold for USD $10.8 Million

2018-07-03 globenewswire
TORONTO, July 03, 2018 (GLOBE NEWSWIRE) -- Amarillo Gold Corporation (“Amarillo” or the “Company”) (TSX.V:AGC) is pleased to report that it has completed the previously-announced sale of a perpetual 1.75% Net Smelter Return Royalty (the “Royalty”) on the Mara Rosa gold project (the “Mara Rosa Project”) to RG Royalties, LLC, a wholly-owned subsidiary of Royal Gold, Inc. (NASDAQ:RGLD) (“Royal Gold”), for USD $10.
AGCBF RGLD AGC RGL

19
U.S. Global's GO GOLD Gold Miners ETF Outperforms GDX And Sprott Gold Miners ETF In Its First Year

2018-07-02 seekingalpha
Last summer, U.S. Global Investors launched a new gold miners ETF, the U.S. Global GO GOLD and Precious Metal Miners ETF.
WPM GDX SGDM FSM SLW TGZ TGZ RGLD SLW GROW FNV RGL

4
The ABSOLUTE Best Way to Invest in the Marijuana Boom

2018-06-30 investorplace
Editor’s note: Below, you’ll find the latest essay in Matt McCall’s series on how to make money during the coming marijuana boom. In this essay, Matt reveals what could turn out to be the ultimate way to invest in legal marijuana.
RGLD FNV.WT.A SLW FNV SLW FNV RGL

7
Golden Star Re-Finances Royal Gold Loan

2018-06-29 seekingalpha
With just two days left in the quarter, Golden Star Resources (GSS) announced that it signed a commitment letter for a $20 million secured with Ecobank Ghana Limited. The loan will be used
RGLD GSS RGL GSC

0
Amarillo Gold Announces the Sale of an NSR Royalty to Royal Gold for USD $10.8 Million

2018-06-29 globenewswire
TORONTO, June 29, 2018 (GLOBE NEWSWIRE) -- Amarillo Gold Corporation (“Amarillo” or the “Company”) (TSX.V:AGC) today announces the entry into an agreement for sale of a perpetual 1.75% Net Smelter Return Royalty on the Mara Rosa gold project (the “Royalty Agreement”) to RG Royalties, LLC, a wholly-owned subsidiary of Royal Gold, Inc. (NASDAQ:RGLD) (“Royal Gold”), for USD $10.8 million (approximately CAD$14.
AGCBF RGLD AGC RGL

6
New Mines Drive Royal Gold, Hurdles at Mount Milligan Ail

2018-06-29 zacks
On Jun 28, we issued an updated research report on Royal Gold, Inc. (RGLD - Free Report) . The company is poised to gain from improved production and progress in ramping up of new mines, as well as its debt-reduction efforts. However, inadequate water supplies at Mount Milligan and volatile gold prices are expected to affect its results. Let’s illustrate these growth factors in detail. Royal Gold to Gain From New Mines Royal Gold expects to start initial production from Peñasquito Pyrite Leach in LaRonde Zone 5 later in calendar year 2018, followed by Cortez Crossroads’ production.
FTI.WI FMC RGLD GM.WS.A KMG GM.WS.B GM.WS.C GM GM.WSB PII MEOH RGL

5
Sandstorm Gold - The Hod Maden Hidden Value

2018-06-28 seekingalpha
On June 26, 2018, Sandstorm Gold released a pre-feasibility study for the Hod Maden gold project in Turkey.
WPM RGLD SAND SSL SDDXF SNXZF MRLDF RGL MARL

1
RGLD / Royal Gold, Inc. 8-K (Current Report)

2018-06-21 sec.gov
UNITED STATES
RGLD

8
Looking For Undervalued Streaming / Royalty Plays

2018-06-21 seekingalpha
It means that the streaming / royalty segment may be an interesting alternative for risk-averse precious metals investors.
WPM SAND SSL FNV.WT.A SDDXF FNV OKSWF MTAFF SNXZF RGLD OR OSKGF MACIF FNV RGL

1
Wheaton Precious Metals Jumps On The Cobalt Train: A Good Decision?

2018-06-13 seekingalpha
Wheaton will pay an upfront payment of $390 million for a right to purchase 42.4% of cobalt production from Voisey's Bay (later to decline to 21.2%).
WPM RGLD SLW SLW RGL

7
Gold: The Running Away Of The Bulls

2018-06-12 seekingalpha
The moving average that tracks bullish sentiment for gold is at its lowest levels in over 18 months.
RGLD GORO RGL

47
Royal Gold: A Streamer Bucking The Trend

2018-06-07 seekingalpha
The company has some of the strongest gross margins of all companies in the S&P 500.
SAND SSL GOOS NGD SDDXF OKSWF NGDAF SNXZF NGD RGLD OR GORO OSKGF RGL GSC

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to RGLD / Royal Gold, Inc. on message board site Silicon Investor.

Royal Gold Inc RGLD: Royal Gold, Inc.
Royal Gold (RGLD)
CUSIP: 780287108